-
Proceedings of the First Annual Meeting of the International Fetoscopic Myelomeningocele Repair Consortium.
Sanz Cortes M, Lapa DA, Acacio GL, Belfort M, Carreras E, Maiz N, Peiro JL, Lim FY, Miller J, Baschat A, Sepulveda G, Davila I, Gielchinsky Y, Benifla M, Stirnemann J, Ville Y, Yamamoto M, Figueroa H, Simpson L, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:855-863. pdf -
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:21-5. -
Frontomaxillary facial angle in fetuses with trisomy 13 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Dagklis T, Faros E, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:819-23. -
Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
Am J Obstet Gynecol 2006;194:397-401. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61. -
Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:411-6. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7.